Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan

被引：0
|
作者：
Suzuki, Sho [1 ,2 ]
Ishibashi, Fumiaki [1 ,2 ]
Gotoda, Takuji [3 ]
机构：
[1] Int Univ Hlth, Dept Gastroenterol, Ichikawa, Japan
[2] Welf Ichikawa Hosp, Ichikawa, Japan
[3] Nihon Univ, Dept Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan
来源：
INTERNAL MEDICINE | 2023年 / 62卷 / 16期
关键词：
Helicobacter pylori; clarithromycin resistance; penicillin allergy; vonoprazan; THERAPY;
D O I：
10.2169/internalmedicine.1282-22
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：2299 / 2300
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter study
    Toshihiko Kakiuchi
    Muneaki Matsuo
    Hiroyoshi Endo
    Yasuhisa Sakata
    Motohiro Esaki
    Takahiro Noda
    Ichiro Imamura
    Kazutoshi Hashiguchi
    Shinichi Ogata
    Yasuhiko Fujioka
    Keiichiro Hanada
    Kayoko Fukuda
    Masaya Yoshimura
    Tetsuro Kajiwara
    Kentaroh Yamamoto
    Daisuke Yamaguchi
    Hiroharu Kawakubo
    Takuya Matsunaga
    Michihiro Sumino
    Keiji Matsunaga
    Eriko Muro
    Akira Watanabe
    Kazuma Fujimoto
    Journal of Gastroenterology, 2023, 58 : 196 - 204
  • [42] Seven-day vonoprazan-based triple therapy as first-line Helicobacter pylori treatment in comparison with extended sequential therapy
    Chiu, Yu-Tse
    Lee, Fu-Jen
    Kuo, Chen-Ya
    Lin, Yang-Chao
    Liang, Kai-Shun
    Tseng, Liang-Wei
    Chen, Yu-Tsung
    Chang, Chi-Yang
    JGH OPEN, 2023, 7 (02): : 105 - 109
  • [43] Effectiveness and safety of vonoprazan-based regimen for Helicobacter pylori eradication: A meta-analysis of randomized clinical trials
    Yang, Chen
    Li, Sai
    Huang, Taoyang
    Lin, Hongju
    Jiang, Zhihui
    He, Yongyang
    Yuan, Junjie
    An, Huijie
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (07) : 897 - 904
  • [44] Successful eradication of Helicobacter pylori infection with vonoprazan-based triple therapy after failure of PPI-based triple therapy
    Kawashima, Kousaku
    Ishihara, Shunji
    Kinoshita, Yoshikazu
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (06) : 688 - 689
  • [45] 14-Day Vonoprazan-Based Bismuth Quadruple Therapy for Treatment-Naive Patients with Helicobacter pylori Infection: A Retrospective Comparative Study
    Lu, Feifei
    Xu, Wentao
    Shi, Xiaoye
    Yu, Honglu
    Qi, Xingshun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 4279 - 4281
  • [46] Metronidazole sensitivity testing of Helicobacter pylori: the importance of media
    Taylor, KJ
    Edwards-Jones, V
    Armitage, M
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 1998, 55 (02) : 118 - 122
  • [47] CLARITHROMYCIN VERSUS METRONIDAZOLE CONTAINING FIRST-LINE VONOPRAZAN BASED TRIPLE THERAPY FOR HELICOBACTER PYLORI: A MULTICENTER, PROSPECTIVE, RANDOMIZED TRIAL IN JAPAN
    Sue, Soichiro
    Arima, Isao
    Hao, Yoshiteru
    Suzuki, Yuichi
    Suzuki, Shingo
    Kaneko, Takashi
    Suzuki, Yoshimasa
    Oka, Hiroyuki
    Amano, Hitoshi
    Ishida, Ayaka
    Mitsui, Tomohiro
    Nakayama, Sae
    Ogushi, Katsuaki
    Kusaka, Eriko
    Kunishi, Yosuke
    Okazaki, Hiroshi
    Komatu, Kazuto
    Naito, Makoto
    Kato, Yoshio
    Shibata, Wataru
    Sasaki, Tomohiko
    Kaneko, Hiroaki
    Irie, Kuniyasu
    Kondo, Masaaki
    Maeda, Shin
    GASTROENTEROLOGY, 2019, 156 (06) : S535 - S535
  • [48] High Body Mass Index Is Correlated with the Success of Vonoprazan-Based Second-Line Therapy for Helicobacter Pylori Infection
    Kasai, Toyotaka
    Suzuki, Sho
    Kusano, Chika
    Ikehara, Hisatomo
    Ichijima, Ryoji
    Ohyauchi, Motoki
    Kawamura, Masashi
    Yoda, Yoshioki
    Nakahara, Moriyasu
    Kawabe, Koichi
    Gotoda, Takuji
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 253 (02): : 85 - 94
  • [49] Vonoprazan for Helicobacter pylori eradication
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (02): : 93 - 93
  • [50] Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents
    Kakiuchi, Toshihiko
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345